Approximately 1.3 thousand deaths due to coronavirus (COVID-19) infection in Romania were reported on June 4, 2020. By September 8, 2024, the number of deaths reached over 68.8 thousand.For further information about the coronavirus (COVID-19) pandemic, please visit our dedicated Facts and Figures page.

Description:

This comprehensive dataset provides global information on both COVID-19 related deaths and vaccinations from January 5, 2020, to August 4, 2024. It consists of two parts: one tracking COVID-19 cases, deaths, and population statistics, and another monitoring vaccination progress worldwide. This dataset allows for an in-depth analysis of the pandemic’s spread, fatality rates, and the effectiveness of vaccination campaigns across various countries and regions.

Researchers and data analysts can use this dataset to study trends, compare countries, and evaluate public health responses throughout the COVID-19 pandemic.

Includes:

CovidDeaths Dataset: Records of total cases, deaths, and population.

CovidVaccinations Dataset: Records of daily vaccination counts and cumulative totals.

Use Cases:

Analyzing death rates relative to confirmed cases. Examining the percentage of population affected by COVID-19. Evaluating vaccination rates and coverage across different regions. This dataset is ideal for data exploration, statistical analysis, and visualizations related to the COVID-19 pandemic.

Due to changes in the collection and availability of data on COVID-19 this page will no longer be updated. The webpage will no longer be available as of 11 May 2023. On-going, reliable sources of data for COVID-19 are available via the COVID-19 dashboard, Office for National Statistics, and the UKHSA

This page provides a weekly summary of data on deaths related to COVID-19 published by NHS England and the Office for National Statistics. More frequent reporting on COVID-19 deaths is now available here, alongside data on cases, hospitalisations, and vaccinations. This update contains data on deaths related to COVID-19 from:

NHS England COVID-19 Daily Deaths - last updated on 28 June 2022 with data up to and including 27 June 2022.


ONS weekly deaths by Local Authority - last updated on 16 August 2022 with data up to and including 05 August 2022.

Summary notes about each these sources are provided at the end of this document.

Note on interpreting deaths data: statistics from the available sources differ in definition, timing and completeness. It is important to understand these differences when interpreting the data or comparing between sources.

Weekly Key Points

An additional 24 deaths in London hospitals of patients who had tested positive for COVID-19 and an additional 5 where COVID-19 was mentioned on the death certificate were announced in the week ending 27 June 2022. This compares with 40 and 3 for the previous week. A total of 306 deaths in hospitals of patients who had tested positive for COVID-19 and 27 where COVID-19 was mentioned on the death certificate were announced for England as whole. This compares with 301 and 26 for the previous week. The total number of COVID-19 deaths reported in London hospitals of patients who had tested positive for COVID-19 is now 19,102. The total number of deaths in London hospitals where COVID-19 was mentioned on the death certificate is now 1,590. This compares to figures of 119,237 and 8,197 for English hospitals as a whole. Due to the delay between death occurrence and reporting, the estimated number of deaths to this point will be revised upwards over coming days These figures do not include deaths that occurred outside of hospitals. Data from ONS has indicated that the majority (79%) of COVID-19 deaths in London have taken place in hospitals.

Recently announced deaths in Hospitals

21 June 22 June 23 June 24 June 25 June 26 June 27 June London No positive test 0 0 1 4 0 0 0 London Positive test 3 7 2 10 0 0 2 Rest of England No positive test 2 6 4 4 0 0 6 Rest of England Positive test 47 49 41 58 6 0 81

16 May 23 May 30 May 06 June 13 June 20 June 27 June London No positive test 14 3 4 0 4 3 5 London Positive test 45 34 55 20 62 40 24 Rest of England No positive test 41 58 33 23 47 23 22 Rest of England Positive test 456 375 266 218 254 261 282 Deaths by date of occurrence

21 June 22 June 23 June 24 June 25 June 26 June 27 June London 20,683 20,686 20,690 20,691 20,692 20,692 20,692 Rest of England 106,604 106,635 106,679 106,697 106,713 106,733 106,742 Interpreting the data The data published by NHS England are incomplete due to:

delays in the occurrence and subsequent reporting of deaths deaths occurring outside of hospitals not being included

The total deaths reported up to a given point are therefore less than the actual number that have occurred by the same point. Delays in reporting NHS provide the following guidance regarding the delay between occurrence and reporting of deaths: Confirmation of COVID-19 diagnosis, death notification and reporting in central figures can take up to several days and the hospitals providing the data are under significant operational pressure. This means that the totals reported at 5pm on each day may not include all deaths that occurred on that day or on recent prior days. The data published by NHS England for reporting periods from April 1st onward includes both date of occurrence and date of reporting and so it is possible to illustrate the distribution of these reporting delays. This data shows that approximately 10% of COVID-19 deaths occurring in London hospitals are included in the reporting period ending on the same day, and that approximately two-thirds of deaths were reported by two days after the date of occurrence.

Deaths outside of hospitals The data published by NHS England does not include deaths that occur outside of hospitals, i.e. those in homes, hospices, and care homes. ONS have published data for deaths by place of occurrence. This shows that, up to 05 August, 79% of deaths in London recorded as involving COVID-19 occurred in hospitals (this compares with 44% for all causes of death). This would suggest that the NHS England data may underestimate overall deaths from COVID-19 by around 20%.

Comparison of data sources

Note on data sources

NHS England provides numbers of patients who have died in hos

Between the beginning of January 2020 and June 14, 2023, of 1,134,660 deaths caused by COVID-19 in the United States, around 742,587 occurred in an inpatient healthcare setting. This statistic shows the number of coronavirus disease 2019 (COVID-19) deaths in the U.S. from January 2020 to June 2023, by place of death.

Between the beginning of January 2020 and June 14, 2023, of the 1,134,641 deaths caused by COVID-19 in the United States, around 307,169 had occurred among those aged 85 years and older. This statistic shows the number of coronavirus disease 2019 (COVID-19) deaths in the U.S. from January 2020 to June 2023, by age.

The COVID-19 dashboard includes data on city/town COVID-19 activity, confirmed and probable cases of COVID-19, confirmed and probable deaths related to COVID-19, and the demographic characteristics of cases and deaths.

United States COVID-19: No. of Deaths: To Date: Ohio data was reported at 43,991.000 Person in 10 Jun 2024. This stayed constant from the previous number of 43,991.000 Person for 09 Jun 2024. United States COVID-19: No. of Deaths: To Date: Ohio data is updated daily, averaging 38,042.000 Person from Jan 2020 (Median) to 10 Jun 2024, with 1602 observations. The data reached an all-time high of 43,991.000 Person in 10 Jun 2024 and a record low of 0.000 Person in 19 Mar 2020. United States COVID-19: No. of Deaths: To Date: Ohio data remains active status in CEIC and is reported by Ohio Department of Health. The data is categorized under High Frequency Database’s Disease Outbreaks – Table US.D001: Center for Disease Control and Prevention: Coronavirus Disease 2019 (COVID-2019).

From August 2024, statistics on confirmed deaths from severe cases of COVID-19 will be provided based on confirmed disease names, time of death, region, age group, and gender. This dataset is updated daily according to a fixed schedule and presents statistics up to the previous day.

As of January 1, 2025, the total number of coronavirus (COVID-19) cases in Italy amounted to over 26.9 million, approximately 218,000 of which were active cases. Moreover, the number of people who recovered or were discharged from hospital after contracting the virus reached over 26.5 million, while the number of deceased was equal to 198,638. For a global overview, visit Statista's webpage exclusively dedicated to coronavirus, its development, and its impact.

Since the spread of the coronavirus (COVID-19) in Italy, started in February 2020, many people who contracted the infection died. The number of deaths amounted to 198,683 as of January 8, 2025. On December 3, 2020, 993 patients died, the highest daily toll since the start of the pandemic. The region with the highest number of deaths was Lombardy, which is also the region that registered the highest number of coronavirus cases. Italy's death toll was one of the most tragic in the world. In the last months, however, the country saw the end to this terrible situation: as of November 2023, roughly 85 percent of the total Italian population was fully vaccinated. For further information about the coronavirus (COVID-19) pandemic, please visit our dedicated Facts and Figures page.

This Dataset contains day-wise cumulative total positive cases, active cases, recoveries and death statistics due to COVID-19 in India up to 10 June 2024

From August 2024, statistics on confirmed cases of death from severe complications of COVID-19, subdivided by confirmed disease name, date of death, region, age group, and gender. This dataset is updated once daily according to a fixed schedule by the system, and presents statistics up to the previous day.

Note: Reporting of new COVID-19 Case Surveillance data will be discontinued July 1, 2024, to align with the process of removing SARS-CoV-2 infections (COVID-19 cases) from the list of nationally notifiable diseases. Although these data will continue to be publicly available, the dataset will no longer be updated.

Authorizations to collect certain public health data expired at the end of the U.S. public health emergency declaration on May 11, 2023. The following jurisdictions discontinued COVID-19 case notifications to CDC: Iowa (11/8/21), Kansas (5/12/23), Kentucky (1/1/24), Louisiana (10/31/23), New Hampshire (5/23/23), and Oklahoma (5/2/23). Please note that these jurisdictions will not routinely send new case data after the dates indicated. As of 7/13/23, case notifications from Oregon will only include pediatric cases resulting in death.

This case surveillance public use dataset has 19 elements for all COVID-19 cases shared with CDC and includes demographics, geography (county and state of residence), any exposure history, disease severity indicators and outcomes, and presence of any underlying medical conditions and risk behaviors.

Currently, CDC provides the public with three versions of COVID-19 case surveillance line-listed data: this 19 data element dataset with geography, a 12 data element public use dataset, and a 33 data element restricted access dataset.

The following apply to the public use datasets and the restricted access dataset:

• Data elements can be found on the COVID-19 case report form located at www.cdc.gov/coronavirus/2019-ncov/downloads/pui-form.pdf.
• Data are considered provisional by CDC and are subject to change until the data are reconciled and verified with the state and territorial data providers.
• Some data are suppressed to protect individual privacy.
• Datasets will include all cases with the earliest date available in each record (date received by CDC or date related to illness/specimen collection) at least 14 days prior to the creation of the current datasets. This 14-day lag allows case reporting to be stabilized and ensure that time-dependent outcome data are accurately captured.
• Datasets are updated monthly.
• Datasets are created using CDC’s Policy on Public Health Research and Nonresearch Data Management and Access and include protections designed to protect individual privacy.
• For more information about data collection and reporting, please see https://www.cdc.gov/coronavirus/2019-ncov/covid-data/about-us-cases-deaths.html.
• For more information about the COVID-19 case surveillance data, please see https://www.cdc.gov/coronavirus/2019-ncov/covid-data/faq-surveillance.html
  

Overview

The COVID-19 case surveillance database includes individual-level data reported to U.S. states and autonomous reporting entities, including New York City and the District of Columbia (D.C.), as well as U.S. territories and affiliates. On April 5, 2020, COVID-19 was added to the Nationally Notifiable Condition List and classified as “immediately notifiable, urgent (within 24 hours)” by a Council of State and Territorial Epidemiologists (CSTE) Interim Position Statement (Interim-20-ID-01). CSTE updated the position statement on August 5, 2020, to clarify the interpretation of antigen detection tests and serologic test results within the case classification (Interim-20-ID-02). The statement also recommended that all states and territories enact laws to make COVID-19 reportable in their jurisdiction, and that jurisdictions conducting surveillance should submit case notifications to CDC. COVID-19 case surveillance data are collected by jurisdictions and reported voluntarily to CDC.

For more information: NNDSS Supports the COVID-19 Response | CDC.

COVID-19 Case Reports COVID-19 case reports are routinely submitted to CDC by public health jurisdictions using nationally standardized case reporting forms. On April 5, 2020, CSTE released an Interim Position Statement with national surveillance case definitions for COVID-19. Current versions of these case definitions are available at: https://ndc.services.cdc.gov/case-definitions/coronavirus-disease-2019-2021/. All cases reported on or after were requested to be shared by public health departments to CDC using the standardized case definitions for lab-confirmed or probable cases. On May 5, 2020, the standardized case reporting form was revised. States and territories continue to use this form.

Data are Considered Provisional

• The COVID-19 case surveillance data are dynamic; case reports can be modified at any time by the jurisdictions sharing COVID-19 data with CDC. CDC may update prior cases shared with CDC based on any updated information from jurisdictions. For instance, as new information is gathered about previously reported cases, health departments provide updated data to CDC. As more information and data become available, analyses might find changes in surveillance data and trends during a previously reported time window. Data may also be shared late with CDC due to the volume of COVID-19 cases.
• Annual finalized data: To create the final NNDSS data used in the annual tables, CDC works carefully with the reporting jurisdictions to reconcile the data received during the year until each state or territorial epidemiologist confirms that the data from their area are correct.

Access Addressing Gaps in Public Health Reporting of Race and Ethnicity for COVID-19, a report from the Council of State and Territorial Epidemiologists, to better understand the challenges in completing race and ethnicity data for COVID-19 and recommendations for improvement.

Data Limitations

To learn more about the limitations in using case surveillance data, visit FAQ: COVID-19 Data and Surveillance.

Data Quality Assurance Procedures

CDC’s Case Surveillance Section routinely performs data quality assurance procedures (i.e., ongoing corrections and logic checks to address data errors). To date, the following data cleaning steps have been implemented:

• Questions that have been left unanswered (blank) on the case report form are reclassified to a Missing value, if applicable to the question. For example, in the question "Was the individual hospitalized?" where the possible answer choices include "Yes," "No," or "Unknown," the blank value is recoded to "Missing" because the case report form did not include a response to the question.
• Logic checks are performed for date data. If an illogical date has been provided, CDC reviews the data with the reporting jurisdiction. For example, if a symptom onset date in the future is reported to CDC, this value is set to null until the reporting jurisdiction updates the date appropriately.
• Additional data quality processing to recode free text data is ongoing. Data on symptoms, race, ethnicity, and healthcare worker status have been prioritized.

Data Suppression

To prevent release of data that could be used to identify people, data cells are suppressed for low frequency (<11 COVID-19 case records with a given values). Suppression includes low frequency combinations of case month, geographic characteristics (county and state of residence), and demographic characteristics (sex, age group, race, and ethnicity). Suppressed values are re-coded to the NA answer option; records with data suppression are never removed.

Additional COVID-19 Data

COVID-19 data are available to the public as summary or aggregate count files, including total counts of cases and deaths by state and by county. These and other COVID-19 data are available from multiple public locations: COVID Data Tracker; United States COVID-19 Cases and Deaths by State; COVID-19 Vaccination Reporting Data Systems; and COVID-19 Death Data and Resources.

Notes:

March 1, 2022: The "COVID-19 Case Surveillance Public Use Data with Geography" will be updated on a monthly basis.

April 7, 2022: An adjustment was made to CDC’s cleaning algorithm for COVID-19 line level case notification data. An assumption in CDC's algorithm led to misclassifying deaths that were not COVID-19 related. The algorithm has since been revised, and this dataset update reflects corrected individual level information about death status for all cases collected to date.

June 25, 2024: An adjustment

Notes:

Based on a comparison of coronavirus deaths in 210 countries relative to their population, Peru had the most losses to COVID-19 up until July 13, 2022. As of the same date, the virus had infected over 557.8 million people worldwide, and the number of deaths had totaled more than 6.3 million. Note, however, that COVID-19 test rates can vary per country. Additionally, big differences show up between countries when combining the number of deaths against confirmed COVID-19 cases. The source seemingly does not differentiate between "the Wuhan strain" (2019-nCOV) of COVID-19, "the Kent mutation" (B.1.1.7) that appeared in the UK in late 2020, the 2021 Delta variant (B.1.617.2) from India or the Omicron variant (B.1.1.529) from South Africa.

The difficulties of death figures

This table aims to provide a complete picture on the topic, but it very much relies on data that has become more difficult to compare. As the coronavirus pandemic developed across the world, countries already used different methods to count fatalities, and they sometimes changed them during the course of the pandemic. On April 16, for example, the Chinese city of Wuhan added a 50 percent increase in their death figures to account for community deaths. These deaths occurred outside of hospitals and went unaccounted for so far. The state of New York did something similar two days before, revising their figures with 3,700 new deaths as they started to include “assumed” coronavirus victims. The United Kingdom started counting deaths in care homes and private households on April 29, adjusting their number with about 5,000 new deaths (which were corrected lowered again by the same amount on August 18). This makes an already difficult comparison even more difficult. Belgium, for example, counts suspected coronavirus deaths in their figures, whereas other countries have not done that (yet). This means two things. First, it could have a big impact on both current as well as future figures. On April 16 already, UK health experts stated that if their numbers were corrected for community deaths like in Wuhan, the UK number would change from 205 to “above 300”. This is exactly what happened two weeks later. Second, it is difficult to pinpoint exactly which countries already have “revised” numbers (like Belgium, Wuhan or New York) and which ones do not. One work-around could be to look at (freely accessible) timelines that track the reported daily increase of deaths in certain countries. Several of these are available on our platform, such as for Belgium, Italy and Sweden. A sudden large increase might be an indicator that the domestic sources changed their methodology.

Where are these numbers coming from?

The numbers shown here were collected by Johns Hopkins University, a source that manually checks the data with domestic health authorities. For the majority of countries, this is from national authorities. In some cases, like China, the United States, Canada or Australia, city reports or other various state authorities were consulted. In this statistic, these separately reported numbers were put together. For more information or other freely accessible content, please visit our dedicated Facts and Figures page.

Over 12 million people in the United States died from all causes between the beginning of January 2020 and August 21, 2023. Over 1.1 million of those deaths were with confirmed or presumed COVID-19.

Vaccine rollout in the United States Finding a safe and effective COVID-19 vaccine was an urgent health priority since the very start of the pandemic. In the United States, the first two vaccines were authorized and recommended for use in December 2020. One has been developed by Massachusetts-based biotech company Moderna, and the number of Moderna COVID-19 vaccines administered in the U.S. was over 250 million. Moderna has also said that its vaccine is effective against the coronavirus variants first identified in the UK and South Africa.

Effective June 7th, 2024, this dataset will no longer be updated.This file contains data on:

1. Cumulative count of Ottawa residents with laboratory-confirmed COVID-19 by episode date (i.e. the earliest of symptom onset, testing or reported date), including active cases and resolved cases.

2. Cumulative count of Ottawa residents with laboratory-confirmed COVID-19 who died by date of death.

3. Daily count of Ottawa residents with laboratory-confirmed COVID-19 by reported date and episode date.

4. Daily count of Ottawa residents with laboratory-confirmed COVID-19 by outbreak association and episode date.

5. Daily count of Ottawa residents with laboratory-confirmed COVID-19 newly admitted to the hospital, currently in hospital, and currently in the intensive care unit (ICU).

6. Cumulative rate of confirmed COVID-19 for Ottawa residents by age group and episode date.

7. Cumulative rate of confirmed COVID-19 for Ottawa residents by gender and episode date.

8. Daily count of Ottawa residents with laboratory-confirmed COVID-19 by source of infection and episode date.

Data are from the Ontario Ministry of Health Public Health Case and Contact Management Solution (CCM).

Accuracy: Points of consideration for interpretation of the data:

The percent of cases with no known epidemiological (epi) link, during the current day and previous 13 days, is calculated as the number of cases with no known epi link among all cases. The percent of cases with no known epi link is unstable during time periods with few cases.

Source of infection is based on a case's epidemiologic linkage. If no epidemiologic linkage is identified, source of infection is allocated using a hierarchy of risk factors: related to travel prior to April 1, 2020 > part of an outbreak > close or household contact of a known case > related to travel since April 1, 2020 > unspecified epidemiological link > no known source of infection > no information available.

Data are entered into and extracted by Ottawa Public Health from the Ontario Ministry of Health Public Health Case and Contact Management Solution (CCM). The CCM is a dynamic disease reporting system that allows for ongoing updates; data represent a snapshot at the time of extraction and may differ from previous or subsequent reports.

As the cases are investigated and more information is available, the dates are updated.

A person’s exposure may have occurred up to 14 days prior to onset of symptoms. Symptomatic cases occurring in approximately the last 14 days are likely under-reported due to the time for individuals to seek medical assessment, availability of testing, and receipt of test results.

Confirmed cases are those with a confirmed COVID-19 laboratory result as per the Ministry of Health Public health management of cases and contacts of COVID-19 in Ontario. March 25, 2020 version 6.0.

Counts will be subject to varying degrees of underreporting due to a variety of factors, such as disease awareness and medical care seeking behaviours, which may depend on severity of illness, clinical practice, changes in laboratory testing, and reporting behaviours.

Data on hospital admissions, ICU admissions and deaths are likely under-reported as these events may occur after the completion of public health follow up of cases. Cases that were admitted to hospital or died after follow-up was completed may not be captured in iPHIS or local health unit reporting tools.

Cases are associated with a specific, isolated community outbreak; an institutional outbreak (e.g. healthcare, childcare, education); or no known outbreak (i.e., sporadic).

The distribution of the source of infection among confirmed cases is impacted by the provincial guidance on testing.

Surveillance testing for COVID-19 began in long term care facilities on April 25, 2020.

Source of infection is allocated using a hierarchy: Related to travel prior to April 1, 2020 > Close contact of a known case or part of a community outbreak or source of infection is an institutional outbreak > Related to travel since April 1, 2020 > No known source of infection > Missing.

The percent of cases with unknown source, during the current day and previous 13 days, is calculated as the number of cases with no known source among cases who source of infection is not an institutional outbreak. Calculated over a 14 day period (i.e. the day of interest and the preceding 13 days). The percent of cases with no known source is unstable during time periods with few cases.

Update Frequency: Wednesdays

Attributes: Data fields:

Data fields:

Date – Date in format YYYY-MM-DD H:MM. The date type varies based on the column of interest and could be:

 - Episode date – Earliest of

symptom onset, test or reported date for cases;

 - Date of death – The date

the person was reported to have died

 - Reported date – Date the

confirmed laboratory results were reported to Ottawa Public Health

 - Hospitalization date

Cumulative Cases by Episode Date – cumulative number of Ottawa residents with laboratory-confirmed COVID-19 by episode date. Cumulative Resolved Cases by Episode Date – cumulative number of Ottawa residents with laboratory-confirmed COVID-19 that have not died and are either (1) assessed as ‘recovered’ in The CCM or (2) 14 days past their episode date and not currently hospitalized. Cumulative Active Cases by Episode Date– cumulative number of Ottawa residents with an active COVID-19 infection. Calculated as the total number of Ottawa residents with COVID-19 excluding resolved and deceased cases. Cumulative Deaths by Date of Death - cumulative number of Ottawa residents with laboratory-confirmed COVID-19 who died by date of death. Deaths are included whether or not COVID-19 was determined to be a contributing or underlying cause of death. Daily Cases by Reported Date – number of Ottawa residents with laboratory-confirmed COVID-19 by reported date 7-Day Average of Newly Reported Cases by Reported Date – number of Ottawa residents with laboratory-confirmed COVID-19 by reported date. Calculated over a 7 day period (i.e. the day of interest and the preceding 6 days). Daily Cases by Episode Date - number of Ottawa residents with laboratory-confirmed COVID-19 by episode date. Daily Cases Linked to a Community Outbreak by Episode Date – number of Ottawa residents with laboratory-confirmed COVID-19 associated with a specific isolated community outbreak by episode date. Daily Cases Linked to an Institutional Outbreak – number of Ottawa residents with laboratory-confirmed COVID-19 associated with a COVID-19 outbreak in a healthcare, childcare or educational establishment by case episode date. Healthcare institutions include places such as long-term care homes, retirement homes, hospitals, other healthcare institutions (e.g. group homes, shelters). Daily Cases Not Linked to an Institutional Outbreak (i.e. Sporadic Cases) – number of Ottawa residents with laboratory-confirmed COVID-19 not associated to an outbreak of COVID-19. Cases Newly Admitted to Hospital – Daily number of Ottawa residents with confirmed COVID-19 admitted to hospital. Emergency room visits are not included in the number of hospital admissions. Cases Currently in Hospital – Number of Ottawa residents with confirmed COVID-19 currently in hospital, includes patients in intensive care. Emergency room visits are not included in the number of hospitalizations. Cases Currently in ICU - Number of Ottawa residents with confirmed COVID-19 currently being treated in the intensive care unit (ICU). It is a subset of the count of hospitalized cases. Cumulative Rate of COVID-19 by 10-year Age Groupings (per 100,000 pop) and Episode Date – The number of Ottawa residents with confirmed COVID-19 within an age group (e.g. 0-9 years) divided by the total Ottawa population for that age group. This fraction is then multiplied by 100,000 to get a rate of COVID-19 per 100,000 population for that age group. Cumulative Rate of COVID-19 by Gender (per 100,000 pop) and Episode Date – The number of Ottawa residents with confirmed COVID-19 of a given gender (e.g. female) divided by the total Ottawa population for that gender. This fraction is then multiplied by 100,000 to get a rate of COVID-19 per 100,000 population for that gender. Source of infection is travel by episode date: individuals who are most likely to have acquired their infection during out-of-province travel. Number of cases with missing information on source of infection by episode date: assessment for source of infection was not completed. Number of cases with no known epidemiological link by episode date: individuals who did not travel outside Ontario, are not part of an outbreak, and are not able to identify someone with COVID-19 from whom they might have acquired infection. The assessment for source of infection was completed, but no sources were identified. Source of infection is a close contact by episode date: individuals presumed to have acquired their infection following close contact (e.g. household member, friend, relative) with an individual with confirmed COVID-19. Source of infection is an outbreak by episode date: individuals who are most likely to have acquired their infection as part of a confirmed COVID-19 outbreak. Source of Infection is Unknown by Episode Date: Ottawa residents with confirmed COVID-19 who did not travel outside

The cumulative number of COVID-19 cases in Spain amounted to nearly 14 million as of May 11, 2025. Since Spain confirmed its first case, the authorities have reported approximately 122,000 deaths as a result of complications stemming from the disease, most of them in Madrid. COVID-19: background information COVID-19 is a disease caused by a novel coronavirus that had not previously been identified in humans. The first case was detected in the Hubei province of China at the end of December 2019. Multiple cases have been reported each day. At the beginning of the pandemic, few was known regarding the virus. Though some aspects still remain unclear, more information has been collected since the outbreak started, allowing a better understanding of the disease and its prevention and treatment, including the production of new vaccines. Immunization in Spain As of May 24, 2023, around 87 percent of the population in Spain had received at least one dose of a vaccine against COVID-19. Moreover, approximately 86 percent were already fully vaccinated. As of August 5, 2022, the number of pre-ordered doses of COVID-19 vaccines in the country amounted to 283.3 million, more than half of which were produced by Pfizer/BioNTech. Find the most up-to-date information about the coronavirus pandemic in the world under Statista’s COVID-19 facts and figures site.

These indicators are designed to accompany the SHMI publication. COVID-19 activity is included in the SHMI if the discharge date is on or after 1 September 2021. Contextual indicators on the number of provider spells which are related to COVID-19 and on the number of provider spells as a percentage of pre-pandemic activity (January 2019 – December 2019) are produced to support the interpretation of the SHMI. The number of spells as a percentage of pre-pandemic activity indicator is being published as an official statistic in development. Official statistics in development are published in order to involve users and stakeholders in their development and as a means to build in quality at an early stage. Notes: 1. There is a shortfall in the number of records for East Cheshire NHS Trust (trust code RJN), Mid Cheshire Hospitals NHS Foundation Trust (trust code RBT), and Wirral University Teaching Hospital NHS Foundation Trust (trust code RBL). Values for these trusts are based on incomplete data and should therefore be interpreted with caution. 2. There is a high percentage of invalid diagnosis codes for Blackpool Teaching Hospitals NHS Foundation Trust (trust code RXL), Chesterfield Royal Hospital NHS Foundation Trust (trust code RFS), County Durham and Darlington NHS Foundation Trust (trust code RXP), Nottingham University Hospitals NHS Trust (trust code RX1), Portsmouth Hospitals University NHS Trust (trust code RHU), Royal United Hospitals Bath NHS Foundation Trust (trust code RD1), The Queen Elizabeth Hospital, King’s Lynn, NHS Foundation Trust (trust code RCX), University Hospitals Birmingham NHS Foundation Trust (trust code RRK), University Hospitals of Morecambe Bay NHS Foundation Trust (trust code RTX), University Hospitals of North Midlands NHS Trust (trust code RJE), University Hospitals Plymouth NHS Trust (trust code RK9) and West Suffolk NHS Foundation Trust (trust code RGR). Values for these trusts should therefore be interpreted with caution. 3. A number of trusts are now submitting Same Day Emergency Care (SDEC) data to the Emergency Care Data Set (ECDS) rather than the Admitted Patient Care (APC) dataset. The SHMI is calculated using APC data. Removal of SDEC activity from the APC data may impact a trust’s SHMI value and may increase it. More information about this is available in the Background Quality Report. 4. Further information on data quality can be found in the SHMI background quality report, which can be downloaded from the 'Resources' section of this page.

Notes: